These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37449932)

  • 1. Drug Interaction Probability Assessment.
    Sohn JT
    Am J Ther; 2023 Jul-Aug 01; 30(4):e391-e394. PubMed ID: 37449932
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological interactions: Horn drug interaction probability scale].
    Juárez-Giménez JC; Lalueza-Broto P; Girona-Brumos L
    Med Clin (Barc); 2008 Feb; 130(3):119. PubMed ID: 18261389
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of drug-target interaction by a random walk with restart method on an interactome network.
    Lee I; Nam H
    BMC Bioinformatics; 2018 Jun; 19(Suppl 8):208. PubMed ID: 29897326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposal for a new tool to evaluate drug interaction cases.
    Horn JR; Hansten PD; Chan LN
    Ann Pharmacother; 2007 Apr; 41(4):674-80. PubMed ID: 17389673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new method for assessing drug causation provided agreement with experts' judgment.
    Arimone Y; Bégaud B; Miremont-Salamé G; Fourrier-Réglat A; Molimard M; Moore N; Haramburu F
    J Clin Epidemiol; 2006 Mar; 59(3):308-14. PubMed ID: 16488362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel integrated action crossing method for drug-drug interaction prediction in non-communicable diseases.
    Hunta S; Yooyativong T; Aunsri N
    Comput Methods Programs Biomed; 2018 Sep; 163():183-193. PubMed ID: 30119852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical relevance of drug interactions].
    Amariles P; Giraldo NA; Faus MJ
    Med Clin (Barc); 2007 Jun; 129(1):27-35. PubMed ID: 17570184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development and evaluation of triage algorithms for early discovery of adverse drug interactions.
    Strandell J; Caster O; Hopstadius J; Edwards IR; Norén GN
    Drug Saf; 2013 May; 36(5):371-88. PubMed ID: 23640657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-learning framework using representation learning to predict drug-drug interaction.
    Deepika SS; Geetha TV
    J Biomed Inform; 2018 Aug; 84():136-147. PubMed ID: 29959033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting drug-drug and drug-gene interactions in a community pharmacy population.
    Dowd D; Williams G; VanDorn D; Clarke S; Krause DS; Botbyl J; Saklad SR
    Am J Manag Care; 2022 Nov; 28(11):566-571. PubMed ID: 36374614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting adverse drug reactions of combined medication from heterogeneous pharmacologic databases.
    Zheng Y; Peng H; Zhang X; Zhao Z; Yin J; Li J
    BMC Bioinformatics; 2018 Dec; 19(Suppl 19):517. PubMed ID: 30598065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A general pharmacodynamic interaction model identifies perpetrators and victims in drug interactions.
    Wicha SG; Chen C; Clewe O; Simonsson USH
    Nat Commun; 2017 Dec; 8(1):2129. PubMed ID: 29242552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new probabilistic rule for drug-dug interaction prediction.
    Zhou J; Qin Z; Quinney SK; Kim S; Wang Z; Yu M; Chien JY; Lucksiri A; Hall SD; Li L
    J Pharmacokinet Pharmacodyn; 2009 Feb; 36(1):1-18. PubMed ID: 19156505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-target interaction prediction using reliable negative samples and effective feature selection methods.
    Sharifabad MM; Sheikhpour R; Gharaghani S
    J Pharmacol Toxicol Methods; 2022; 116():107191. PubMed ID: 35738316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L
    Cui Z; Gao YL; Liu JX; Dai LY; Yuan SS
    BMC Bioinformatics; 2019 Jun; 20(Suppl 8):287. PubMed ID: 31182006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, outcomes research, and drug interactions.
    Schein JR
    Drug Metabol Drug Interact; 1998; 14(3):147-58. PubMed ID: 10366991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Algorithms used in adverse drug event reports: a comparative study.
    Frick PA; Cohen LG; Rovers JP
    Ann Pharmacother; 1997 Feb; 31(2):164-7. PubMed ID: 9034415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for estimating pharmacokinetic risks of concentration-dependent drug interactions from preclinical data.
    Ramanathan M
    Drug Metab Dispos; 1999 Dec; 27(12):1479-87. PubMed ID: 10570030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for assessing the probability of toxicity from drug interactions having a pharmacokinetic basis.
    Sullivan TJ; Bachmann KA
    Clin Pharm; 1990 Feb; 9(2):136-9. PubMed ID: 2306924
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of individual and population bioequivalence using the probability that bioavailabilities are similar.
    Schall R
    Biometrics; 1995 Jun; 51(2):615-26. PubMed ID: 7662849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.